Company Quick10K Filing
Burzynski Research Institute
10-Q 2020-05-31 Filed 2020-07-15
10-K 2020-02-29 Filed 2020-05-28
10-Q 2019-11-30 Filed 2020-01-14
10-Q 2019-08-31 Filed 2019-10-15
10-Q 2019-05-31 Filed 2019-07-15
10-K 2019-02-28 Filed 2019-05-29
10-Q 2018-11-30 Filed 2019-01-14
10-Q 2018-08-31 Filed 2018-10-15
10-Q 2018-05-31 Filed 2018-07-16
10-K 2018-02-28 Filed 2018-05-22
10-Q 2017-11-30 Filed 2018-01-16
10-Q 2017-08-31 Filed 2017-10-16
10-Q 2017-05-31 Filed 2017-07-17
10-K 2017-02-28 Filed 2017-05-11
10-Q 2016-11-30 Filed 2017-01-17
10-Q 2016-08-31 Filed 2016-10-14
10-Q 2016-05-31 Filed 2016-07-15
10-K 2016-02-29 Filed 2016-06-13
10-Q 2015-11-30 Filed 2016-01-14
10-Q 2015-08-31 Filed 2015-10-15
10-Q 2015-05-31 Filed 2015-07-15
10-K 2015-02-28 Filed 2015-05-29
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-15
10-Q 2014-05-31 Filed 2014-07-15
10-K 2014-02-28 Filed 2014-05-30
10-Q 2013-11-30 Filed 2014-01-14
10-Q 2013-08-31 Filed 2013-10-15
10-Q 2013-05-31 Filed 2013-07-15
10-K 2013-02-28 Filed 2013-05-29
10-Q 2012-11-30 Filed 2013-01-14
10-Q 2012-08-31 Filed 2012-10-15
10-Q 2012-05-31 Filed 2012-07-16
10-K 2012-02-29 Filed 2012-05-29
10-Q 2011-11-30 Filed 2012-01-17
10-Q 2011-08-31 Filed 2011-10-17
10-Q 2011-05-31 Filed 2011-07-15
10-K 2011-02-28 Filed 2011-05-31
10-Q 2010-11-30 Filed 2011-01-14
10-Q 2010-08-31 Filed 2010-10-15
10-Q 2010-05-31 Filed 2010-07-15
10-K 2010-02-28 Filed 2010-06-01
10-Q 2009-11-30 Filed 2010-01-14

Burzynski Research Institute Financials

BZYR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Amedica (AMDA) 5,471 35% 0.1 -97% 14,397 6,307 6,764 2,378 -14,003 -13,648 -1,322
Biorestorative Therapies (BRTX) 5,455 0% -0.4 -898% 1,458 13,887 98 0 -13,097 -12,936 5,514
Laredo Oil (LRDC) 5,451 2% -45.9 -41% 357 2,059 8,480 196 -146 -113 5,162
Gridiron Bionutrients (GMVP) 5,358 -44% -5.9 -275% 331 252 83 -37 -913 -910 5,344
Ocean Thermal Energy (CPWR) 5,371 -14.4 -9,953% 16 18,829 0 0 -1,616 -849 12,206
Rodin Income Trust (RIT) 5,367 10.2 2% 26,379 15,997 0 0 460 460 4,682
Oculus (OVTZ) 5,362 -19.3 -62% 414 137 0 0 -257 -257 4,949
Flux Power Holdings (FLUX) 5,360 7% -0.4 -153% 9,009 15,541 9,401 653 -13,827 -13,827 5,197
Vicon Industries (VII) 5,344 40% -2.3 -36% 12,428 12,454 21,238 8,559 -4,426 -3,951 8,944
DigiPath (DIGP) 5,320 38% -4.1 -120% 1,356 930 1,901 726 -1,628 -1,386 5,696
GraniteShares Platinum Trust (PLTM) 5,316 12.8 7% 5,803 2 0 0 415 415 5,316
AgriTek Holdings (AGTK) 5,274 -1.1 -647% 1,411 8,631 0 0 -9,129 -6,760 7,144
Burzynski Research Institute (BZYR) 5,258 0% 13 213 0 0 0 0 5,255
Apex 2 (APEX) 5,204 -109.3 -241% 20 230 0 0 -47 -47 5,184
Timberline Resources (TLRS) 5,122 -3.2 -9% 15,551 1,069 0 0 -1,433 -1,580 5,008
US Rare Earth Minerals (USMN) 5,118 -4.4 -3,599% 33 1,214 0 0 -1,196 -1,169 5,085
Amarc Resources (AXREF) 5,118 0% 799 1,342 0 0 0 0 4,945
uSell.com (USEL) 5,104 2% -0.1 -121% 11,276 10,072 74,171 1,568 -13,622 -10,652 1,124
ROI Land Investments (ROII) 5,064 -0.4 -64% 25,790 42,491 0 0 -16,488 -14,985 6,465
Penn Virginia (PVA) 5,004 95% 2.5 6% 1,211,780 695,122 347,299 330,362 67,290 225,983 564,017

Balance Sheet ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash2216171514311100262201131011013100013
Accounts Receivable
Inventory
PP&E443333223222222222111221002222
Assets262021181764432248442214111110136291745342213
Accounts Payable341255115348401531631141081139110082938764467949206061684265969810197
Long-Term Debt
Liabilities37486213646908913717919515313413711514213213512810563110734489129163137153213206209213
Stockholders' Equity-10-28-41-118-28-85-85-133-176-193-151-130-130-111-138-131-133-126-101-62-109-72-33-89-128-127-108-137-167-172-187-200
Income Statement ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue0000000000000000
Cost of Revenue
Gross Profit
R&D1,7411,7641,9861,5381,4971,4301,5821,2131,021937792780704654570572486433357349310348318368345343244281308322235333
SG&A44754614229799-871441304533603853475225275320923532951605880129141118104136
Tax00000000
Net Income
Cash Flow ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating-117-116-139-289-110-133-163-91-87-98-129-76-113-36-79-33-46-94-78-61-92-84-55-70-106-116-126-106-136
Cash Investing
Cash Financing11011713728899132163908698131791093777334696766192845473103116126106138